Skip to main content

Day: May 10, 2024

Doman Building Materials Group Ltd. Announces Meeting Results for Election of Directors

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, May 10, 2024 (GLOBE NEWSWIRE) — Doman Building Materials Group Ltd. (“Doman”) or the “Company”) (TSX:DBM) announced its director election results following its annual and special meeting of shareholders, held May 9, 2024. All of the nominees proposed as directors in the Company’s Management Information Circular, dated March 22, 2024, were elected on a vote by show of hands. In total 33,931,707 shares were represented in person or by proxy at the meeting, representing approximately 38.9% of the outstanding shares as of the record date of March 18, 2024. The proxies received by management for the election of directors were as...

Continue reading

Smart for Life to Attend Vitafoods Europe 2024: Positioned to Identify Strategic Partnerships and Potential Acquisitions

Renowned Industry Leader and Smart for Life Board Member Heather Granato to Speak at Nutraceutical Event in Geneva, Switzerland MIAMI, May 10, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a distinguished leader in the Health & Wellness sector specializing in the marketing and manufacturing of nutritional supplements and foods, today announced its participation in Vitafoods Europe 2024, scheduled to take place in Geneva, Switzerland from May 14 to 16, 2024. Vitafoods Europe is a premier event in the nutraceutical industry, typically attracting over 25,000 industry experts, and is renowned for its spotlight on the latest advancements and trends shaping the future of health and wellness. Smart for Life’s presence at Vitafoods Europe signifies a meaningful opportunity for...

Continue reading

Mobile-health Network Solutions Expands Services to Malaysia

SINGAPORE, May 10, 2024 (GLOBE NEWSWIRE) — Mobile-health Network Solutions (Nasdaq: MNDR) (“MaNaDr” or “the Company”), a leading Asia-Pacific telehealth provider, today announced the establishment of a subsidiary in Malaysia. This strategic expansion signifies MNDR’s commitment to delivering accessible and affordable healthcare services throughout Southeast Asia. Solidifying Regional Leadership The Malaysian subsidiary marks a pivotal step in the Company’s growth trajectory. It positions the Company as a frontrunner in telemedicine solutions across Southeast Asia, enabling MNDR to cater to the region’s evolving healthcare needs. This expansion fosters wider patient reach and brand recognition, solidifying the Company’s position as a leader in the burgeoning telemedicine landscape. Tailored Service Offerings The...

Continue reading

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems

LAS VEGAS, May 10, 2024 (GLOBE NEWSWIRE) — Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence (AI) technology company specializing in the development of advanced AI and data center infrastructure solutions, today announced that it plans to equip its AI-managed data center, currently in development, with High-Performance Computing (HPC) systems. This state-of-the-art facility will enable Avant to accelerate its advancements in AI and deliver groundbreaking solutions for its clients. This next-generation facility signifies Avant’s commitment to pushing the boundaries of data center efficiency and empowering its clients with the incredible power of AI. “The rise of AI is revolutionizing industries, and Avant Technologies is committed to being at the forefront of this transformation,” said...

Continue reading

Eezy Plc – Manager’s Transactions – DG Holding Oy

EEZY PLC — MANAGERS TRANSACTIONS — 10 MAY 2024 AT 15:00 Eezy Oyj – Managers’ Transactions____________________________________________Person subject to the notification requirementName: DG Holding OyPosition: Member of the Board/Deputy member(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Markus JussilaPosition: Other senior managerIssuer: Eezy OyjLEI: 743700ZKOMTB7X00OW54Notification type: INITIAL NOTIFICATIONReference number: 62245/10/10____________________________________________Transaction date: 2024-05-08Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000322326Nature of transaction: ACQUISITION Transaction details(1): Volume: 10000 Unit price: 1.3 EUR Aggregated transactions (1):Volume: 10000 Volume weighted average price: 1.3 EURAdditional information:Ilpo...

Continue reading

Testing, Inspection, and Certification (TIC) Market to Surpass USD 358 Billion by 2031 | SkyQuest Technology

Westford, USA, May 10, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Testing, Inspection, And Certification (TIC) Market will attain a value of USD 358 billion by 2031, with a CAGR of 5.30% during the forecast period (2024-2031). Testing, inspection, and certification, or TIC, refers to a range of services that include auditing, inspection, product and equipment certification, testing, verification, and quality assurance. By lowering risk, these aid in boosting production efficiency and lowering mistake. The oil and gas, food, pharmaceutical, chemical, and other industries can all benefit from TIC services. Download a detailed overview: https://www.skyquestt.com/sample-request/testing-inspection-and-certification-market Browse in-depth TOC on the ” Testing, Inspection, And Certification (TIC) Market ”Pages –...

Continue reading

Dycom Industries, Inc. to Host Fiscal 2025 First Quarter Results Conference Call

PALM BEACH GARDENS, Fla., May 10, 2024 (GLOBE NEWSWIRE) — Dycom Industries, Inc. (NYSE: DY) will host a conference call to discuss fiscal 2025 first quarter results on Wednesday, May 22, 2024, at 9:00 a.m. Eastern time. Dycom will issue a press release reporting its results earlier that morning. Interested parties may participate in the question and answer session of the conference call by registering at https://register.vevent.com/register/BI1c2e72a7bcd9487582598a90de01968e. Upon registration, participants will receive a dial-in number and unique PIN to access the call. Participants are encouraged to join approximately ten minutes prior to the scheduled start time. For all other attendees, a live listen-only audio webcast of the call, including an accompanying slide presentation, can be accessed directly at https://edge.media-server.com/mmc/p/pyhc9s3t....

Continue reading

Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

— Announced FDA clearance of first-ever IND application for a Prime Editing product, PM359, for the treatment of CGD; initial data from planned Phase 1/2 clinical trial expected in 2025 — — Presented new preclinical data demonstrating broad potential of Prime Editing technology at LNP Formulation and Process Development Summit and ASGCT 2024 — — Appointed Tony Coles, M.D. as senior advisor — CAMBRIDGE, Mass., May 10, 2024 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today reported financial results for the first quarter ended March 31, 2024, and provided a business update. “In 2024, we expect to bring the first-ever Prime Editing-based product candidate to patients, while...

Continue reading

Creative Realities Reports Fiscal 2024 First Quarter Results

Strong Revenue Growth, Refinancing Underway, 2024 Outlook Reaffirmed LOUISVILLE, Ky., May 10, 2024 (GLOBE NEWSWIRE) — Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage and media solutions, announced its financial results for the fiscal first quarter ended March 31, 2024. Highlights:Record first quarter revenue of $12.3 million, up 24% from $9.9 million in the prior-year period Gross profit of $5.8 million for the three months ended March 31, 2024 versus $5.1 million in the first quarter of fiscal 2023 Adjusted EBITDA* of $0.8 million for the first quarter of 2024 versus $1.0 million in the prior-year period Annual recurring revenue (“ARR”) of approximately $17.7 million at the end of the first quarter versus $16.3 million at the beginning of the fiscal...

Continue reading

Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update

FARMINGTON HILLS, Mich., May 10, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing small molecule therapies for the treatment of patients with retinal and refractive eye disorders, today announced financial results for the first quarter ended March 31, 2024, and provided a corporate update. “Ocuphire has made significant progress in 2024, with important developments for both APX3330 and RYZUMVI™,” said George Magrath, M.D., M.B.A., M.S., CEO of Ocuphire. “We have been engaged in productive dialogue with the U.S. Food and Drug Administration (FDA) with respect to our submitted Special Protocol Assessment (SPA) to formalize the protocol and statistical analysis plan for future Phase 2/3 registrational trials of APX3330 in diabetic retinopathy...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.